Search
for
Sort by
Research 181–210 of 1000+
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- No Association between Serum Ferritin Levels >10 μg/l and Hair Loss Activity in Women
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- TOXIC EPIDERMAL NECROLYSIS
- Melatonin promotes secondary hair follicle development of early postnatal cashmere goat and improves cashmere quantity and quality by enhancing antioxidant capacity and suppressing apoptosis
- Hormonal treatment of acne vulgaris: an update
- Endocrine-skin interactions
- Acne in the adult female patient: a practical approach
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Pharmacotherapy of polycystic ovary syndrome - an update
- Platelet‐rich plasma, a powerful tool in dermatology
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Gender-Affirming Hormone Therapy for Transgender Females
- Polycystic ovary syndrome: A review for dermatologists
- ANDROGENETIC ALOPECIA
- Finasteride Treatment of Hair Loss in Women
- Relative Safety and Efficacy of Finasteride for Treatment of Hirsutism
- Obesity and the Polycystic Ovary Syndrome
- Polycystic ovarian syndrome
- Trichotillomania in children and adolescents: Review of the literature and case report
- Hirsutism: diagnosis and treatment
- Prospective metabolic evaluation of 150 consecutive patients who underwent gastric exclusion
- Physiologic changes and dermatoses of pregnancy
- Thyroid antibodies in Hashimoto’s thyroiditis patients are positively associated with inflammation and multiple symptoms
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations